Varaico: Literature-Extracted Genetic Variants

Gene:DCTD
Variant:p.N58D
Back to variants list

DCTD

NM_001921.3:p.N58D

Associated Papers

Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy.

Amaki J et al.

International Journal of Hematology, 2015

The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma.

Erčulj N et al.

Pharmacogenetics and Genomics, 2012

Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.

Okazaki T et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2010

Genetic factors influencing cytarabine therapy.

Lamba JK

Pharmacogenomics, 2009

Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics.

Gilbert JA et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2006

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."